KURA ONCOLOGY, INC.: 10-Q filed 2011-08-15

Name: KURA ONCOLOGY, INC.: 10-Q filed 2011-08-15
Creator: KURA ONCOLOGY, INC.

What KURA ONCOLOGY, INC. reported in its quarterly report filed 2011-08-15 (fiscal Q2 2011): 15 published measures, 50 facts as tagged in accession 0001144204-11-047066.

This filing

Form: 10-Q (quarterly report)
Filed: 2011-08-15
Fiscal period: fiscal Q2 2011
Accession: 0001144204-11-047066 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KURA ONCOLOGY, INC. filings.

Reported measures

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-06-30	-52,880	USD
At 2010-12-31	-40,991	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-08-09	5,760	USD
At 2011-06-30	9,255	USD
At 2010-12-31	26,898	USD
At 2010-06-30	5,760	USD
At 2009-12-31	11,142	USD
At 2007-11-15	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-6,735	USD	91
2011-01-01 to 2011-06-30	-11,889	USD	181
2007-11-16 to 2011-06-30	-102,880	USD	1323
2010-04-01 to 2010-06-30	-5,576	USD	91
2010-01-01 to 2010-06-30	-9,882	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	-17,643	USD	181
2007-11-16 to 2011-06-30	-100,745	USD	1323
2010-01-01 to 2010-06-30	-15,382	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	0	USD	181
2007-11-16 to 2011-06-30	110,000	USD	1323
2010-01-01 to 2010-06-30	10,000	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-5,837	USD	91
2011-01-01 to 2011-06-30	-10,104	USD	181
2007-11-16 to 2011-06-30	-98,370	USD	1323
2010-04-01 to 2010-06-30	-5,121	USD	91
2010-01-01 to 2010-06-30	-9,057	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-06-30	15,505	USD
At 2010-12-31	29,398	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	898	USD	91
2011-01-01 to 2011-06-30	1,785	USD	181
2007-11-16 to 2011-06-30	4,510	USD	1323
2010-04-01 to 2010-06-30	455	USD	91
2010-01-01 to 2010-06-30	825	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-06-30	68,385	USD
At 2010-12-31	70,389	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-06-30	2,200	USD
At 2010-12-31	2,064	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-06-30	5,000,000	shares
At 2010-12-31	5,000,000	shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2011-06-30	6,185	USD
At 2010-12-31	8,325	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	5,837	USD	91
2011-01-01 to 2011-06-30	10,104	USD	181
2007-11-16 to 2011-06-30	82,727	USD	1323
2010-04-01 to 2010-06-30	5,121	USD	91
2010-01-01 to 2010-06-30	9,057	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	0	USD	181
2007-11-16 to 2011-06-30	50,000	USD	1323
2010-01-01 to 2010-06-30	0	USD	181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	136	USD	181
2007-11-16 to 2011-06-30	2,200	USD	1323
2010-01-01 to 2010-06-30	0	USD	181

Inspect the source

Entity: KURA ONCOLOGY, INC. / CIK 0001422143
Captured: 2026-09-20T08:03:22.155Z
SEC response SHA-256: 99c25996d2b94a162f8d422ab44911c7e1eca886397d9f5849b0bd5c004a4e4f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001422143.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))